Individuals with obesity were at least two times more likely to develop certain types of cancer and 3.5 times more likely to die from from the disease than those who had weight-loss surgery, according to a new study presented ...
Jun 7, 2022
0
6
University of North Carolina Lineberger Comprehensive Cancer Center scientists have developed preclinical laboratory models of the two most common types of kidney cancer, an advancement that may aid in the evaluation of novel ...
Jun 9, 2017
0
21
One of the first studies to investigate the outcome of COVID-19 infection in patients with blood cancer has been conducted by clinical researchers from Queen Mary University of London and Barts Health NHS Trust.
Jun 2, 2020
0
4
Mount Sinai researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically ...
Aug 2, 2019
0
1
Researchers at the University of Bergen have discovered that a drug against kidney cancer possibly can fight several types of cancer.
Sep 29, 2016
0
24
City of Hope, one of the largest cancer research and treatment organizations in the United States, and Osel Inc., a company developing live biotherapeutic products for modulation of the human microbiome, today announced Phase ...
Feb 28, 2022
0
7
New research offers yet another reason why Americans should cut back on their soda consumption: Drinking too many sugary beverages may increase the risk of death from cancer.
Sep 15, 2022
0
49
People are living much longer worldwide than they were two decades ago, as death rates from infectious diseases and cardiovascular disease have fallen, according to a new, first-ever journal publication of country-specific ...
Dec 17, 2014
0
0
(Medical Xpress) -- Nearly two-thirds (65%) of adult New Zealanders are consuming more sodium than current nutrition guidelines recommend, according to analysis of urine samples taken from 3000 people who took part in the ...
Dec 2, 2011
0
0
(AP) -- A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman.
Dec 7, 2011
0
0
